ArticleMethods in enzymology2025
A robust protocol for refolding TolC and other outer membrane components of tripartite efflux pumps from inclusion bodies.
Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Antibiotic resistance is a growing threat in the modern world. In Gram-negative bacteria, one factor contributing to antibiotic resistance is the tripartite efflux pumps which push antibiotics out of the cell against their concentration gradient. These pumps consist of three main protein complexes: an outer membrane protein, an inner membrane protein, and the periplasmic adapter protein, which connects the two membrane proteins. Multiple efflux pumps in resistant strains use the same outer membrane protein, TolC. This protein is a homotrimeric transmembrane membrane beta barrel with a periplasmic homotrimeric alpha-helical barrel. Until recently, isolation of folded TolC from the outer membrane was quite difficult, leading to low yields. Our lab developed an inclusion body isolation and refolding protocol to increase the yield of trimeric TolC. We identified two crucial factors that support TolC refolding: detergent choice and protein concentration and found that this method is also successful for some TolC homologs (V. cholerae VceC and C. jejuni CmeC). This chapter seeks to provide an in-depth guide for investigators wanting to refold TolC or its homologs, by giving insight into common pitfalls and other issues we have noted in our work.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.